NATURES SUNSHINE PRODUCTS INC

Listed Company

NATRCIK 0000275053NasdaqAcceleratedSmaller ReportingPharmaceutical PreparationsUtahFY ends Dec 31

Period

FY 2024

Revenue

$454.36M

Net Income

$7.70M

Total Assets

$240.85M

Equity

$160.99M

Shares Out

17.51M

Op. Cash Flow

$25.30M

Business

NATURES SUNSHINE PRODUCTS INC is a natural health and wellness company engaged in manufacturing and direct selling of nutritional and personal care products. It offers over 800 products across categories such as general health, immune, cardiovascular, digestive, personal care and weight management, produced in company and contract manufacturing facilities. The company reports four business segments—Asia, Europe, North America and Latin America and Other—including a wholesale distribution channel in Latin America. Products are sold primarily through a network of independent consultants and regional or third‑party warehouses in international markets.

Summary from filing dated 2025-03-11

Financials

Consolidated Statement of Income

Year Ended · In millions, except per-share amounts

Concept	FY 2024 2024-12-31	FY 2023 2023-12-31	FY 2022 2022-12-31	FY 2021 2021-12-31	FY 2020 2020-12-31
Net sales	454	445	422	444	385
Cost of sales	−130	−124	−122	−115	−101
Gross profit	325	321	300	329	284
Volume incentives	141	135	130	140	131
Selling, general and administrative	164	167	153	154	131
Operating income	20	19	16	35	21
Interest and other income, net	177,000	552,000	123,000	466,000	171,000
Interest expense	−146,000	−69,000	—	—	—
Foreign exchange gains (losses), net	−2	970,000	−917,000	−3	1
Other income (expense), net	−2	1	−1	−3	1
Income from operations before provision for income taxes	18	20	15	32	23
Provision for income taxes	11	4	15	2	−137,000
Net income	8	16	550,000	30	23
Net income attributable to noncontrolling interests	196,000	1	940,000	1	2
Net income attributable to common shareholders	8	15	−390,000	—	—
Basic earnings (loss) per share attributable to common shareholders (in dollars per share)	0.41	0.79	−0.02	1.45	1.09
Diluted earnings (loss) per share attributable to common shareholders (in dollars per share)	0.4	0.77	−0.02	1.42	1.07
Weighted average basic common shares outstanding (in shares)	19	19	19	20	20
Weighted average diluted common shares outstanding (in shares)	19	19	19	20	20

Consolidated Balance Sheet

As of · In millions, except per-share amounts

Concept	FY 2024 2024-12-31	FY 2023 2023-12-31	FY 2022 2022-12-31	FY 2021 2021-12-31	FY 2020 2020-12-31
Cash and cash equivalents	85	82	60	86	92
Accounts receivable, net of allowance for doubtful accounts of $97 and $142, respectively	9	9	14	9	7
Inventories	59	67	68	61	48
Prepaid expenses and other	7	8	7	9	7
Total current assets	161	166	150	165	154
Property, plant and equipment, net	40	45	46	51	54
Operating lease right-of-use assets	13	13	16	18	20
Restricted investment securities - trading	900,000	700,000	700,000	1	1
Deferred income tax assets	18	15	7	14	9
Other assets	9	10	10	10	11
Total Assets	241	250	230	259	249
Accounts payable	9	8	6	10	6
Accrued volume incentives and service fees	21	23	22	23	19
Accrued liabilities	25	33	26	32	32
Deferred revenue	3	2	2	4	2
Income taxes payable	4	6	4	3	2
Current portion of operating lease liabilities	4	5	4	4	5
Total current liabilities	66	77	66	77	70
Liability related to unrecognized tax benefits	628,000	312,000	209,000	—	—
Long-term portion of operating lease liabilities	10	10	14	16	16
Deferred compensation payable	915,000	747,000	702,000	964,000	989,000
Long-term deferred income tax liabilities	1	1	1	2	1
Other liabilities	1	644,000	1	1	1
Total liabilities	80	90	83	97	92
Common stock, no par value; 50,000 shares authorized, 18,483 and 18,875 shares issued and outstanding as of December 31, 2024, and 2023, respectively	115	120	122	133	139
Retained earnings	57	50	35	35	26
Noncontrolling interests	6	5	4	3	2
Accumulated other comprehensive loss	−17	−15	−13	−10	−10
Total shareholders equity	161	160	147	161	157
Total Liabilities and Shareholders' Equity	241	250	230	259	249

Consolidated Statement of Cash Flows

Year Ended · In millions, except per-share amounts

Concept	FY 2024 2024-12-31	FY 2023 2023-12-31	FY 2022 2022-12-31	FY 2021 2021-12-31	FY 2020 2020-12-31
Provision for doubtful accounts	0	45,000	45,000	−47,000	77,000
Depreciation and amortization	14	12	11	11	11
Noncash lease expense	5	4	—	—	—
Share-based compensation expense	5	5	3	4	4
Loss on disposal or sale of property and equipment	2	0	1	−28,000	29,000
Deferred income taxes	−2	−9	7	—	—
Purchase of trading investment securities	−141,000	0	−32,000	−36,000	−60,000
Proceeds from sale of trading investment securities	97,000	97,000	134,000	175,000	339,000
Realized and unrealized gains on investments	−124,000	−140,000	160,000	−105,000	−115,000
Foreign exchange (gains) losses	2	−970,000	917,000	3	−1
Accounts receivable	−1	5	−6	−2	106,000
Inventories	6	995,000	−9	−14	−154,000
Prepaid expenses and other	528,000	−683,000	552,000	−2	−2
Other assets	−560,000	679,000	159,000	182,000	−55,000
Accounts payable	1	1	−3	3	2
Accrued volume incentives and service fees	−2	1	−329,000	4	77,000
Accrued liabilities	−6	7	−6	402,000	5
Deferred revenue	1	−456,000	−1	2	766,000
Lease liabilities	−6	−5	—	—	—
Income taxes payable	−3	3	1	−393,000	671,000
Liability related to unrecognized tax positions	419,000	103,000	218,000	−92,000	−1
Deferred compensation payable	168,000	43,000	−262,000	−21,000	−164,000
Net cash provided by operating activities	25	41	710,000	35	38
Purchases of property, plant and equipment	−11	−10	−8	−7	−5
Net cash used in investing activities	−11	−10	−8	−7	−5
Proceeds from revolving credit facility	41	16	45	—	—
Principal payments of revolving credit facility	−41	−16	−45	—	—
Principal payments of long-term debt	0	−1	−1	−1	−5
Payments related to tax withholding for net-share settled equity awards	−1	−385,000	−1	−2	—
Repurchase of common stock	−9	−6	−14	−7	0
Net cash used in financing activities	−10	−8	−16	−32	4
Effect of exchange rates on cash and cash equivalents	−2	−451,000	−3	−2	2
Net increase in cash and cash equivalents	2	22	−26	−6	38
Cash paid for income taxes, net of refunds	15	9	—	—	—
Cash paid for interest	119,000	539,000	264,000	202,000	86,000
Purchases of property, plant and equipment included in accounts payable and accrued liabilities	201,000	590,000	375,000	330,000	85,000

Filings

Filing historySign up free to browse every 10-K, 10-Q, 8-K, and proxy this filer has submitted to the SEC.Sign up free · Upgrade to Pro

Material Events

Material EventsTrack every 8-K filing and material event — AI-summarized, timelined, and alertable.Sign up free · Upgrade to Pro

Insiders

Insider ActivitySee executive buy/sell windows and insider trade activity over rolling 30/90/365-day windows.Sign up free · Upgrade to Pro

Institutional Holders

Institutional HoldersSee which funds hold this stock and track position changes quarter over quarter.Sign up free · Upgrade to Pro